AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

MedLife S.A.

Regulatory Filings Nov 15, 2024

2292_iss_2024-11-15_c525a201-ee6e-41b0-b3d6-62ff6793209e.pdf

Regulatory Filings

Open in Viewer

Opens in native device viewer

MED LIFE S.A. Registered Office: Bucharest, 365, Calea Grivitei, 1st district, Romania Unique Registration Code at the National Office of Trade Registry: 8422035 Order number on the Trade Registry: J40/3709/1996 Subscribed and paid-in share capital: 132,870,492 RON

To: BUCHAREST STOCK EXCHANGE FINANCIAL SUPERVISORY AUTHORITY

ANNOUNCEMENT

Report Date: 15 November 2024 Name of the issuing company: MED LIFE S.A. ("MedLife" or "the Company") Registered Office: Bucharest, Calea Grivitei, no. 365, district 1, Romania Telephone / Fax number: 0374 180 470 Unique Registration Code at the National Office of Trade Registry: 8422035 Order number on the Trade Registry: J40/3709/1996 Subscribed and paid-in share capital: 132,870,492 RON Total number of shares: 531,481,968 531,481,968 (out of which 417,042 own shares, without voting rights and 531,064,926 shares with voting rights) Regulated market on which the issued securities are traded: Bucharest Stock Exchange, Premium Category

Availability of the Q3 2024 results Conference Call presentation

MED LIFE S.A. informs shareholders and investors about the availability, on the company's website, in the Investor Relations section / Reports and Presentations / Financial Reports (https://www.medlife.ro/investor-relations/reports-and-presentations/financial-reports) and on the Bucharest Stock Exchange's website (symbol M) of the Presentation related to the Q3 2024 results Conference Call with analysts and investors.

Mihail Marcu Chief Executive Officer

______________

Talk to a Data Expert

Have a question? We'll get back to you promptly.